Summary
applying collateral estopple to a decision awarding one party attorneys’ fees under to 35 U.S.C. § 285 in a related case
Summary of this case from In re Outlaw Lab., LLP.Opinion
2016-2094
08-10-2017
AIA AMERICA, INC., FKA ALZHEIMER'S INSTITUTE OF AMERICA, INC., Plaintiff-Appellant MICHAEL J. MULLAN, RONALD E. SEXTON, Counterclaim Defendants v. ELI LILLY & COMPANY, ELAN PHARMACEUTICALS, INC., Defendants-Appellees
PETER BUCKLEY, Fox Rothschild, LLP, Philadelphia, PA, argued for plaintiff-appellant. DEBORAH E. FISHMAN, Arnold & Porter Kaye Scholer LLP, Palo Alto, CA, argued for all defendants-appellees. Defendant-appellee Elan Pharmaceuticals, Inc. also represented by KATIE JEANNINE LEWIS SCOTT. LAWRENCE SCOTT BURWELL, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Reston, VA, for defendant-appellee Eli Lilly & Company. Also represented by CHARLES E. LIPSEY; LAURA POLLARD MASUROVSKY, Washington, DC; MANISHA A. DESAI, Eli Lilly and Company, Indianapolis, IN.
NOTE: This disposition is nonprecedential. Appeal from the United States District Court for the Northern District of California in No. 3:10-cv-00482-EDL, Magistrate Judge Elizabeth D. Laporte.
JUDGMENT
PETER BUCKLEY, Fox Rothschild, LLP, Philadelphia, PA, argued for plaintiff-appellant. DEBORAH E. FISHMAN, Arnold & Porter Kaye Scholer LLP, Palo Alto, CA, argued for all defendants-appellees. Defendant-appellee Elan Pharmaceuticals, Inc. also represented by KATIE JEANNINE LEWIS SCOTT. LAWRENCE SCOTT BURWELL, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Reston, VA, for defendant-appellee Eli Lilly & Company. Also represented by CHARLES E. LIPSEY; LAURA POLLARD MASUROVSKY, Washington, DC; MANISHA A. DESAI, Eli Lilly and Company, Indianapolis, IN. THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:
PER CURIAM (NEWMAN, LOURIE, and HUGHES, Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT August 10, 2017
Date
/s/ Peter R. Marksteiner
Peter R. Marksteiner
Clerk of Court